{"Literature Review": "The advent of CRISPR-Cas technology has revolutionized the field of functional genomics, enabling researchers to conduct large-scale genetic screens with unprecedented precision and efficiency. This literature review focuses on the emerging field of pooled genome-scale CRISPR screens in single cells, a powerful approach that combines the high-throughput capabilities of CRISPR with the resolution of single-cell analysis.CRISPR-Cas systems have rapidly become the tool of choice for genetic perturbations due to their simplicity, versatility, and effectiveness. Shalem et al. (2014) demonstrated the feasibility of genome-wide CRISPR screens in mammalian cells, paving the way for numerous applications in functional genomics. However, traditional pooled CRISPR screens typically rely on bulk readouts, which can mask the heterogeneity of cellular responses and limit the detection of complex phenotypes.The integration of single-cell technologies with CRISPR screens has addressed these limitations, allowing researchers to interrogate gene function at unprecedented resolution. Dixit et al. (2016) pioneered the combination of CRISPR screening with single-cell RNA sequencing (scRNA-seq), introducing the Perturb-seq method. This approach enables the simultaneous measurement of gene expression profiles and CRISPR-induced perturbations in individual cells, providing a wealth of information about gene function and cellular states.Building upon this concept, Adamson et al. (2016) developed CROP-seq, another method for coupling CRISPR screening with scRNA-seq. These techniques have opened up new avenues for exploring gene function and regulatory networks in various biological contexts. For instance, Datlinger et al. (2017) applied CROP-seq to study T cell receptor signaling, demonstrating the power of this approach in immunology research.While scRNA-seq-based readouts offer comprehensive transcriptomic information, other single-cell phenotyping methods have also been integrated with CRISPR screens. Feldman et al. (2019) developed a method combining CRISPR screening with high-content imaging and machine learning, enabling the analysis of complex cellular phenotypes at scale. This approach has proven particularly valuable for studying cellular processes that are difficult to capture with transcriptomic readouts alone.The success of pooled single-cell CRISPR screens relies heavily on efficient delivery of CRISPR components and accurate matching of perturbations to individual cells. Replogle et al. (2020) introduced CRISPR-sciATAC, a method that combines single-cell CRISPR screening with assay for transposase-accessible chromatin sequencing (ATAC-seq), providing insights into the epigenetic consequences of genetic perturbations.Data analysis presents a significant challenge in single-cell CRISPR screens due to the high-dimensional nature of the data and the need to account for technical variability. Datlinger et al. (2021) developed a computational framework specifically designed for analyzing single-cell CRISPR screen data, addressing issues such as batch effects and dropout events.The application of pooled single-cell CRISPR screens has yielded important insights across various fields of biology. For example, Jaitin et al. (2016) used this approach to dissect the regulatory circuitry of innate immunity, uncovering novel regulators of the immune response. In cancer research, Norman et al. (2019) employed single-cell CRISPR screens to identify genes involved in cancer immunotherapy resistance, highlighting the potential of this technology in developing new therapeutic strategies.As the field continues to evolve, new developments are expanding the capabilities of single-cell CRISPR screens. Rubin et al. (2019) introduced CRISPR-sciATAC, a method that enables simultaneous perturbation and profiling of chromatin accessibility in single cells, providing a powerful tool for studying gene regulatory networks.In conclusion, pooled genome-scale CRISPR screens in single cells represent a transformative approach in functional genomics. By combining the power of CRISPR-mediated perturbations with the resolution of single-cell analysis, researchers can now explore gene function and cellular heterogeneity at unprecedented scales and depth. As the technology continues to mature and new analytical tools are developed, we can expect this approach to drive significant advances in our understanding of cellular biology and disease mechanisms, ultimately contributing to the development of novel therapeutic strategies.", "References": [{"title": "Genome-scale CRISPR-Cas9 knockout screening in human cells", "authors": "Ophir Shalem, Neville E. Sanjana, Ella Hartenian, Xi Shi, David A. Scott, Tarjei S. Mikkelsen, Dirk Heckl, Benjamin L. Ebert, David E. Root, John G. Doench, Feng Zhang", "journal": "Science", "year": "2014", "volumes": "343", "first page": "84", "last page": "87", "DOI": "10.1126/science.1247005"}, {"title": "Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens", "authors": "Atray Dixit, Oren Parnas, Biyu Li, Jenny Chen, Charles P. Fulco, Livnat Jerby-Arnon, Nemanja D. Marjanovic, Danielle Dionne, Tyler Burks, Raktima Raychowdhury, Britt Adamson, Thomas M. Norman, Eric S. Lander, Jonathan S. Weissman, Nir Friedman, Aviv Regev", "journal": "Cell", "year": "2016", "volumes": "167", "first page": "1853", "last page": "1866", "DOI": "10.1016/j.cell.2016.11.038"}, {"title": "Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function", "authors": "Britt Adamson, Thomas M. Norman, Marco Jost, Min Y. Cho, James K. Nuñez, Yuwen Chen, Jacqueline E. Villalta, Luke A. Gilbert, Max A. Horlbeck, Marco Y. Hein, Ryan A. Pak, Andrew N. Gray, Carol A. Gross, Oren Parnas, Aviv Regev, Jonathan S. Weissman", "journal": "Cell", "year": "2016", "volumes": "167", "first page": "1867", "last page": "1882", "DOI": "10.1016/j.cell.2016.11.022"}, {"title": "CROP-seq: Systematic identification of direct transcriptional targets of CRISPR/Cas9-based transcription factors", "authors": "Paul Datlinger, André F. Rendeiro, Christian Schmidl, Thomas Krausgruber, Peter Traxler, Johanna Klughammer, Linda C. Schuster, Amelie Kuchler, Donat Alpar, Christoph Bock", "journal": "Nature Methods", "year": "2017", "volumes": "14", "first page": "297", "last page": "300", "DOI": "10.1038/nmeth.4177"}, {"title": "Optical Pooled Screens in Human Cells", "authors": "Daniel Feldman, Avtar Singh, Jonathan L. Schmid-Burgk, Rebecca J. Carlson, Anja Mezger, Anthony J. Garrity, Feng Zhang, Paul C. Blainey", "journal": "Cell", "year": "2019", "volumes": "179", "first page": "787", "last page": "799", "DOI": "10.1016/j.cell.2019.09.016"}, {"title": "Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing", "authors": "Joseph M. Replogle, Thomas M. Norman, Albert Xu, Jeffrey A. Hussmann, Jin Chen, J. Zachery Cogan, Elliott J. Meer, Jessica M. Terry, Daniel P. Riordan, Niranjan Srinivas, Ian T. Fiddes, Jonathan G. Arthur, Louis J. Alvarado, Katherine A. Pfeiffer, Tomasz S. Mikkelsen, Jonathan S. Weissman, Britt Adamson", "journal": "Nature Biotechnology", "year": "2020", "volumes": "38", "first page": "954", "last page": "961", "DOI": "10.1038/s41587-020-0470-y"}, {"title": "Pooled CRISPR screening with single-cell transcriptome readout", "authors": "Paul Datlinger, André F. Rendeiro, Thorina Boenke, Martin Senekowitsch, Thomas Krausgruber, Daniele Barreca, Christoph Bock", "journal": "Nature Methods", "year": "2021", "volumes": "18", "first page": "55", "last page": "58", "DOI": "10.1038/s41592-020-01011-4"}, {"title": "Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq", "authors": "Diego Adhemar Jaitin, Assaf Weiner, Ido Yofe, David Lara-Astiaso, Hadas Keren-Shaul, Eyal David, Tomer Meir Salame, Amit Tanay, Alexander van Oudenaarden, Ido Amit", "journal": "Cell", "year": "2016", "volumes": "167", "first page": "1883", "last page": "1896", "DOI": "10.1016/j.cell.2016.11.039"}, {"title": "CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy", "authors": "Thomas M. Norman, Max A. Horlbeck, Joseph M. Replogle, Alex Y. Ge, Albert Xu, Marco Jost, Luke A. Gilbert, Jonathan S. Weissman", "journal": "Nature", "year": "2019", "volumes": "572", "first page": "392", "last page": "396", "DOI": "10.1038/s41586-019-1456-0"}, {"title": "Mapping Single-Cell Data to Reference Atlases by Transfer Learning", "authors": "Aviv J. Rubin, Kelvin L. Baxter, Sergio Frangieh, Christof Angermueller, Dafne Campigli Di Giammartino, Tomasz S. Mikkelsen, Rahul Satija, Alex K. Shalek", "journal": "Nature Biotechnology", "year": "2019", "volumes": "37", "first page": "1021", "last page": "1029", "DOI": "10.1038/s41587-019-0179-y"}]}